Jul. 11, 2012 at 4:13pm
StrykerRejuvenateABG IIABG II RecallsRejuvenate RecallsStryker RecallsStryker Recall LawsuitsDefective Rejuvenate HipDefective ABG II HipMetal on Metal Hip JointsHip Joint RecallsJoint RecallsDePuy ASRFDAFood Drug Administration
In late June 2012, the U.S. Food & Drug Administration (“FDA”) held hearings over the course of 2 days to consider growing concerns and evidence relating to Metal on Metal (MoM) hip implants, resurfacing devices and other issues. While most Americans celebrated mid-week July 4th, #STRYKER, a major manufacturer of hip implants announced that it was #recalling a failing component in its line of modular hip implants. By July 6th, PR releases from the company entitled “Stryker Initiates Voluntary Product Recall of Modular-Neck Stems, Action Specific to Rejuvenate and ABG II Modular-Neck Stems” announed that post-market surveillance had revealed potential risks of fretting and corrosion at the modular neck junction. This means that part of the joint, a stem like area that joined other components was failing and leading to serious complications and potential health risks for patients. The image above is from Recall Attorneys / Recall Lawyers on Facebook. All of the surrounding PR and little news that has been publicized over this #recall highlights the fact that noone is putting a number on how many failed modular neck stems were manufactured, sold or implanted. Wonder if that is a deliberate failure on the part of #Stryker, or is it indicative of the fact that noone really knows. Until the dust settles on this #recall noone will know. Lawsuits related to the failure are imminent as patient advocates circle the wagons to seek answers and redress. Additional information on existing Joint Recalls and related the ongoing investigation of the failure rate surrounding the previously recalled DePuy ASR, and now the Stryker Rejuvenate and ABG II Modular Neck Stems is available by contacting the sponsor of this site here.

In late June 2012, the U.S. Food & Drug Administration (“FDA”) held hearings over the course of 2 days to consider growing concerns and evidence relating to Metal on Metal (MoM) hip implants, resurfacing devices and other issues.

While most Americans celebrated mid-week July 4th, #STRYKER, a major manufacturer of hip implants announced that it was #recalling a failing component in its line of modular hip implants. By July 6th, PR releases from the company entitled “Stryker Initiates Voluntary Product Recall of Modular-Neck Stems, Action Specific to Rejuvenate and ABG II Modular-Neck Stems” announed that post-market surveillance had revealed potential risks of fretting and corrosion at the modular neck junction. This means that part of the joint, a stem like area that joined other components was failing and leading to serious complications and potential health risks for patients.

The image above is from Recall Attorneys / Recall Lawyers on Facebook. All of the surrounding PR and little news that has been publicized over this #recall highlights the fact that noone is putting a number on how many failed modular neck stems were manufactured, sold or implanted. Wonder if that is a deliberate failure on the part of #Stryker, or is it indicative of the fact that noone really knows. Until the dust settles on this #recall noone will know. Lawsuits related to the failure are imminent as patient advocates circle the wagons to seek answers and redress.

Additional information on existing Joint Recalls and related the ongoing investigation of the failure rate surrounding the previously recalled DePuy ASR, and now the Stryker Rejuvenate and ABG II Modular Neck Stems is available by contacting the sponsor of this site here.